10X Genomics (TXG) shares slumped 26% pre-bell Thursday after the company reported preliminary Q3 sales that trailed analysts' projections.
E2open Parent Holdings (ETWO) shares dropped 22% after the company reported lower fiscal Q2 revenue and cut its full-year revenue guidance.
Mersana Therapeutics (MRSN) shares retreated 21%, adding to Wednesday's 5.5% loss.
Indivior (INDV) shares fell 17% after the company lowered its fiscal year 2024 revenue guidance.
Price: 15.39, Change: -5.42, Percent Change: -26.05
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments